Back to Journals » Journal of Hepatocellular Carcinoma » Volume 5 » default

Impact Factor

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969


       

Archive: Volume 5, 2018

Original Research

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I

Journal of Hepatocellular Carcinoma 2018, 5:109-119

Published Date: 19 November 2018

Review

Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist

Quaglia A

Journal of Hepatocellular Carcinoma 2018, 5:99-108

Published Date: 8 November 2018

Review

Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein

Gilabert M, Raoul JL

Journal of Hepatocellular Carcinoma 2018, 5:91-98

Published Date: 2 November 2018

Review

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)

de Jesus VHF, Dettino ALA

Journal of Hepatocellular Carcinoma 2018, 5:87-90

Published Date: 3 October 2018

Original Research

Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

Dandachi D, Hassan M, Kaseb A, Angelidakis G, Torres HA

Journal of Hepatocellular Carcinoma 2018, 5:81-86

Published Date: 2 August 2018

Review

Hepatocellular cancer pain: impact and management challenges

Christian-Miller N, Frenette C

Journal of Hepatocellular Carcinoma 2018, 5:75-80

Published Date: 19 July 2018

Review

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM

Journal of Hepatocellular Carcinoma 2018, 5:61-73

Published Date: 27 June 2018

Case Series

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

Griffith AS, Hayashi PH, Burke LMB, McRee AJ

Journal of Hepatocellular Carcinoma 2018, 5:55-59

Published Date: 31 May 2018

Editorial

Editorial: charting the future of hepatocellular carcinoma publications

Kaseb AO

Journal of Hepatocellular Carcinoma 2018, 5:51-54

Published Date: 8 May 2018

Review

Basic MRI for the liver oncologists and surgeons

Vu LN, Morelli JN, Szklaruk J

Journal of Hepatocellular Carcinoma 2018, 5:37-50

Published Date: 10 April 2018

Clinical Trial Report

Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

Shaker MK, Montasser IF, Sakr M, Elgharib M, Dabbous HM, Ebada H, El Dorry A, Bahaa M, El Meteini M

Journal of Hepatocellular Carcinoma 2018, 5:29-36

Published Date: 27 February 2018

Review

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma

Najjar M, Agrawal S, Emond JC, Halazun KJ

Journal of Hepatocellular Carcinoma 2018, 5:17-28

Published Date: 18 January 2018

Original Research

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N

Journal of Hepatocellular Carcinoma 2018, 5:9-15

Published Date: 12 January 2018

Original Research

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

Liang B, Yao SY, Zhou JP, Li ZK, Liu TQ

Journal of Hepatocellular Carcinoma 2018, 5:1-7

Published Date: 12 January 2018